13 May 2021 - Outpatient visit restrictions imposed in early 2020 due to COVID-19 increased demand for effective virtual health care interventions. Telemedicine visits skyrocketed in the first half of last year. 

However, while federal agencies have taken significant action to shore up telemedicine use, short of a few regulatory carve outs for remote patient monitoring and mental health, digital therapeutics have been left by the wayside.

Read Health Affairs Blog